Evidence map›Paper›PMID 40722142›Full record

ArticleBMC medical imaging2025

Unveiling key pathomic features for automated diagnosis and Gleason grade estimation in prostate cancer.

Valentina Brancato, Mario Verdicchio, Carlo Cavaliere, Francesco Isgrò, Marco Salvatore, Marco Aiello

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valentina BrancatoIRCCS SYNLAB SDN, Via E. Gianturco 113, 80143, Naples, Italy. valentina.brancato@synlab.it.
Mario VerdicchioIRCCS SYNLAB SDN, Via E. Gianturco 113, 80143, Naples, Italy.
Carlo CavaliereIRCCS SYNLAB SDN, Via E. Gianturco 113, 80143, Naples, Italy.
Francesco IsgròDepartment of Electrical Engineering and Information Technologies, University of Naples Federico II, Claudio 21, 80125, Naples, Italy.
Marco SalvatoreIRCCS SYNLAB SDN, Via E. Gianturco 113, 80143, Naples, Italy.
Marco AielloIRCCS SYNLAB SDN, Via E. Gianturco 113, 80143, Naples, Italy.

Funding

European Commission 101100633-EUCAIMMinistero della Salute Ricerca Corrente
6 · The paper itself

Abstract

backgroundRecent advances in histology scanning technology and Artificial Intelligence (AI) offer great opportunities to support cancer diagnosis. The inability to interpret the extracted features and model predictions is one of the major issues limiting the acceptance of AI models in clinical practice, and a clear representation of the relevance of the extracted features and model predictions is lacking. Focusing on the problem of prostate cancer (PCa) diagnosis and grading, this study aims to detect which are the most discriminant features for distinguishing malignant from non-malignant tissue and Gleason patterns, leaving the evaluation of models' classification performances as a secondary goal.

methodsUtilizing a dataset of 187 annotated H&E-stained whole-slide images, the study explores three magnification levels, extracting 1971 features per tile. Two machine-learning classification tasks are conducted (Malignant vs. Non-malignant and High-grade vs. Low-grade) for each magnification. SHapley Additive exPlanations method was used to investigate models' interpretability, estimating the importance of pathomic features and their impact on prediction models.

resultsWavelet features were consistently prominent in "High-grade vs Low-grade" classification task, together with local binary pattern descriptors. Some histogram features appeared as key features for diagnostic classification tasks. The identified key discriminant features were classified for their specificity with respect to WSI magnification. Very high AUC values were reached for PCa diagnosis task (0.97 < AUC < 0.99), while task involving Low- versus High-grade classification exhibit lower AUC values (maximum AUC: 0.72-0.73).

conclusionsThis work provides new insights for the explanation of hand-crafted pathomic-based classification models for PCa diagnosis and grading. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Image Interpretation, Computer-AssistedProstatic NeoplasmsHumansMachine LearningMaleNeoplasm GradingDecision support systemsDigital pathologyGleason gradePathomicsProstate cancer

Identifiers

PMID40722142
PMCPMC12305976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.